Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states.

Authors: Kim, DS  Li, KW  Boroujerdi, A  Peter Yu, Y  Zhou, CY  Deng, P  Park, J  Zhang, X  Lee, J  Corpe, M  Sharp, K  Steward, O  Eroglu, C  Barres, B  Zaucke, F  Xu, ZC  Luo, ZD 
Citation: Kim DS, etal., J Neurosci. 2012 Jun 27;32(26):8977-87. doi: 10.1523/JNEUROSCI.6494-11.2012.
Pubmed: (View Article at PubMed) PMID:22745497
DOI: Full-text: DOI:10.1523/JNEUROSCI.6494-11.2012

Neuropathic pain is a common cause of pain after nerve injury, but its molecular basis is poorly understood. In a post-gene chip microarray effort to identify new target genes contributing to neuropathic pain development, we report here the characterization of a novel neuropathic pain contributor, thrombospondin-4 (TSP4), using a neuropathic pain model of spinal nerve ligation injury. TSP4 is mainly expressed in astrocytes and significantly upregulated in the injury side of dorsal spinal cord that correlates with the development of neuropathic pain states. TSP4 blockade by intrathecal antibodies, antisense oligodeoxynucleotides, or inactivation of the TSP4 gene reverses or prevents behavioral hypersensitivities. Intrathecal injection of TSP4 protein into naive rats is sufficient to enhance the frequency of EPSCs in spinal dorsal horn neurons, suggesting an increased excitatory presynaptic input, and to cause similar behavioral hypersensitivities. Together, these findings support that injury-induced spinal TSP4 may contribute to spinal presynaptic hypersensitivity and neuropathic pain states. Development of TSP4 antagonists has the therapeutic potential for target-specific neuropathic pain management.

Annotation

Gene Ontology Annotations
Objects Annotated

Additional Information

 
CRRD Object Information
CRRD ID: 8553360
Created: 2014-05-08
Species: All species
Last Modified: 2014-05-08
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.